In the latest trading session,, 0.73 million Regencell Bioscience Holdings Ltd (NASDAQ:RGC) shares changed hands as the company’s beta touched 2.34. With the company’s most recent per share price at $10.6 changed hands at -$4.0 or -27.40% at last look, the market valuation stands at $5.24B. RGC’s current price is a discount, trading about -688.68% off its 52-week high of $83.60. The share price had its 52-week low at $0.08, which suggests the last value was 99.25% up since then. When we look at Regencell Bioscience Holdings Ltd’s average trading volume, we note the 10-day average is 1.68 million shares, with the 3-month average coming to 2.97 million.
Regencell Bioscience Holdings Ltd (NASDAQ:RGC) trade information
Instantly RGC was in red as seen in intraday trades today. With action -51.22%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 9969.75%, with the 5-day performance at -51.22% in the red. However, in the 30-day time frame, Regencell Bioscience Holdings Ltd (NASDAQ:RGC) is -46.15% down. Looking at the short shares, we see there were 1.05 million shares sold at short interest cover period of 0.73 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -60.65%.
RGC Dividends
Regencell Bioscience Holdings Ltd is expected to release its next quarterly earnings report in August.
Regencell Bioscience Holdings Ltd (NASDAQ:RGC)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 93.84% of Regencell Bioscience Holdings Ltd shares while 0.07% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.10%. There are 0.07% institutions holding the Regencell Bioscience Holdings Ltd stock share, with UBS GROUP AG the top institutional holder. As of 2024-06-30, the company held 0.0024% of the shares, roughly 312.0 RGC shares worth $1048.0.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 0.0018% or 238.0 shares worth $800.0 as of 2024-06-30.
With 259.01 shares estimated at $2.73 million under it, the former controlled 1.99% of total outstanding shares.
